Targeting FcRn to Generate Antibody-Based Therapeutics: From Discovery to Pre-clinical Translation

Time: 9:30 am
day: Day Two

Details:

  • Identification of FcRn as the global regulator of IgG levels, leading to FcRn antagonist technology.
  • Targeting FcRn to selectively deplete antigen-specific antibodies.

Speakers: